1. Sausville EA, Feigal E . Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA Ann Oncol 1999 10: 1287–1291
2. Sausville E, Shoemaker R . Role of the national cancer institute in acquired immunodeficiency syndrome-related drug discovery J Natl Cancer Inst Monogr 2001 28: 55–57
3. Hodes L . Selection of molecular fragment features for structure–activity studies in antitumor screening J Chem Inf Comput Sci 1981 21: 132–136
4. Driscoll JS . The pre-clinical new drug research program of the National Cancer Institute Cancer Treat Rep 1984 68: 63–76
5. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL . Feasibility of drug screening with panels of human tumor cell lines using a micro culture tetrazolium assay Cancer Res 1988 48: 589–601